Online ‘quality assured’ API trading platform to launch this year

By Flora Southey

- Last updated on GMT

Kemiex has established an online platform to facilitate the trade of active pharmaceutical ingredients between drugmakers and distributors.

The B2B platform is designed to securely exchange active pharmaceutical ingredients (APIs) and additives between traders, buyers and sellers – all of which are required to meet predefined quality assurance requisites and financial criteria.

“Kemiex contributes to the digitalisation of pharma supply chains – as well as veterinary, human and animal nutrition industries – and specifically makes the activities of buying and selling APIs and additives safer and more convenient,” ​chief marketing officer Stefan Schmidinger told us.

“The platform connects companies to a global network that is compliant with latest regulations and quality controls,” ​he added.

Trade credit insurance – provided by strategic partner Atradius – is available for transactions 24/7.

The revenue model – under which sellers will pay less than 2% for every deal successfully closed on the platform – is based on successful transactions – there is no advertising or hidden fees, we were told.

Platform trading will officially launch later this year.

Schmidinger told us the site is now open for registration, adding: “Onboarding and demo presentation is a bespoke process for selected, reputable companies.”

In 2016, pharmaceutical consultancy firm Rephine told​ in-PharmaTechnologist it also hoped to launch an online API platform, but with a focus on good manufacturing practice (GMP) audits and supplier databases. 

Earlier this year, the firm launched​ the database, which is designed to address the burden of ingredient supplier validation. 

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us


View more